Join us at Health Research Day — June 6th at Canton Waterfront Park, Baltimore!   Learn More →
← Back to all trials
Recruiting NCT05628701

Colectomy Reconstruction for Ulcerative Colitis, Ileorectal Anastomosis vs Ileal Pouch-Anal Anastomosis in Ulcerative Colitis.

Conditions: Ulcerative Colitis, Inflammatory Bowel Diseases, Ileostomy - Stoma

Sex: All
Ages: 18 Years – 60 Years
Phase: NA
Enrollment: 100
Sponsor: Linkoeping University

Location: Sweden

Summary

Background There are no prospective trials comparing the two main reconstructive options after colectomy for Ulcerative colitis, ileal pouch anal anastomosis and ileorectal anastomosis. An attempt on a randomized controlled trial has been made but after receiving standardized information patients insisted on choosing operation themselves.Methods Adult Ulcerative colitis patients subjected to colectomy eligible for both ileal pouch anastomosis and ileorectal anastomosis are asked to participate and after receiving standardized information the get to choose reconstructive method. Patients not declining reconstruction or not considered eligible for both methods will be followed as controls. The CRUISE study is a prospective, non-randomized, multi-center, controlled trial on satisfaction, QoL, function, and complications between ileal pouch anal anastomosis and ileorectal anastomosis.Discussion Reconstruction after colectomy is a morbidity-associated as well as a resource-intensive activity with the sole purpose of enhancing function, Quality of Life and patient satisfaction. The aim of this study is to provide the best possible information on the risks and benefits of each reconstructive treatment.

Eligibility Criteria

Inclusion criteria:Patients with Ulcerative colitis (UC) aged between 18 and 60Scheduled for or have previously undergone subtotal colectomy and ileostomy.Patients should have sufficient rectal compliance and controllable inflammation in the rectal using topical Mezalasin only.Exclusion criteriaRectal inflammation of Mayo Score >1Poor sphincter function, perianal diseaseUncertainty regarding UC diagnosis PPrevious colorectal cancer or severe dysplasiaPrimary Sclerosing Colitis diagnosis>2 year since subtotal colectomy

Interested in this study? View the official listing for contact and enrollment details.

View on ClinicalTrials.gov

Source: ClinicalTrials.gov (NCT05628701). StuddyBuddy aggregates publicly available trial information.